Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| (NASDAQ: XERS) | Delayed: 10.07 +0.30 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.77 | 52 Week High | $ | |||
| Open | $9.77 | 52 Week Low | $ | |||
| Day High | $10.18 | P/E | N/A | |||
| Day Low | $9.76 | EPS | $ | |||
| Volume | 1,941,740 | |||||
